CareDx Quarterly Cash Flow Statement
NASDAQ: CDNAHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
CareDx free cash flow
In the quarter ended Jun 30, 2026, CareDx generated $30.6 million of operating cash flow and spent $1.9 million on capital expenditures. That left free cash flow of $28.7 million, a free-cash-flow margin of 21.8% of revenue. Free cash flow was up 223.4% from the prior year's $8.9 million.
Summary generated from market data by MetaCap's automated system. Methodology
CareDx cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 110.64M | 2.81M | -4.11M | 1.68M | -8.57M | -10.35M | 87.70M | -7.41M | -1.39M | -16.66M | -118.10M | -23.48M |
| Net Income growth (YoY) | — | — | -104.68% | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 2.81M | 3.90M | 3.88M | 3.81M | 3.72M | 3.60M | 3.36M | 3.47M | 3.54M | 3.82M | 3.63M | 3.66M |
| Stock-Based Compensation | 10.65M | 9.80M | 8.09M | 8.42M | 9.42M | 8.93M | 16.51M | 16.92M | 16.40M | 16.57M | 9.96M | 12.67M |
| Change in Working Capital | 5.51M | -2.76M | 4.96M | 20.69M | 1.49M | -8.94M | 2.09M | 397.00K | -8.98M | -13.37M | -39.00K | -132.00K |
| Operating Cash Flow | 30.60M | 4.33M | 21.36M | 37.36M | 9.89M | -26.58M | 21.89M | 12.52M | 18.95M | -15.31M | -8.38M | -10.18M |
| Capital Expenditures | -1.86M | -3.82M | — | — | -1.01M | -1.63M | — | — | — | — | — | — |
| Investing Cash Flow | 280.59M | 11.06M | -34.91M | 12.35M | 23.40M | 1.32M | -2.11M | -14.41M | -11.63M | 27.66M | 41.37M | -1.50M |
| Share Repurchases | — | — | -12.21M | -25.56M | -50.00M | 0 | 0 | 0 | 0 | -522.00K | -25.97M | -814.00K |
| Financing Cash Flow | -15.50M | -2.91M | -12.46M | -26.48M | -53.81M | -643.00K | -903.00K | 1.42M | -4.85M | -1.27M | -26.88M | -25.00K |
| Net Change in Cash | 295.68M | 12.49M | -26.01M | 23.22M | -20.53M | -25.98M | 19.28M | -378.00K | 2.49M | 11.10M | 6.22M | -11.81M |
| Free Cash Flow | 28.75M | 514.00K | 21.36M | 37.36M | 8.89M | -28.21M | 21.89M | 12.52M | 18.95M | -15.31M | -8.38M | -10.18M |
This table shows 12 quarterly periods of CareDx's cash flow statement, from Q2 2026 back to Q3 2023, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow CDNA's reporting calendar. What is a cash flow statement?